NRIX
Price
$15.94
Change
-$0.61 (-3.69%)
Updated
Feb 5, 04:59 PM (EDT)
Capitalization
1.64B
67 days until earnings call
Intraday BUY SELL Signals
SNDX
Price
$20.15
Change
-$0.28 (-1.37%)
Updated
Feb 5 closing price
Capitalization
1.75B
31 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs SNDX

Header iconNRIX vs SNDX Comparison
Open Charts NRIX vs SNDXBanner chart's image
Nurix Therapeutics
Price$15.94
Change-$0.61 (-3.69%)
Volume$23.55K
Capitalization1.64B
Syndax Pharmaceuticals
Price$20.15
Change-$0.28 (-1.37%)
Volume$1.67M
Capitalization1.75B
NRIX vs SNDX Comparison Chart in %
NRIX
Daily Signal:
Gain/Loss:
SNDX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRIX vs. SNDX commentary
Feb 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and SNDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 06, 2026
Stock price -- (NRIX: $16.55 vs. SNDX: $20.43)
Brand notoriety: NRIX and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 59% vs. SNDX: 66%
Market capitalization -- NRIX: $1.64B vs. SNDX: $1.75B
NRIX [@Biotechnology] is valued at $1.64B. SNDX’s [@Biotechnology] market capitalization is $1.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $116.41B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, both NRIX and SNDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 3 TA indicator(s) are bullish while SNDX’s TA Score has 2 bullish TA indicator(s).

  • NRIX’s TA Score: 3 bullish, 5 bearish.
  • SNDX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both NRIX and SNDX are a bad buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а -7.39% price change this week, while SNDX (@Biotechnology) price change was -0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.10%. For the same industry, the average monthly price growth was -2.90%, and the average quarterly price growth was +28.24%.

Reported Earning Dates

NRIX is expected to report earnings on Apr 14, 2026.

SNDX is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (-7.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.75B) has a higher market cap than NRIX($1.64B). SNDX YTD gains are higher at: -2.761 vs. NRIX (-12.757). NRIX has higher annual earnings (EBITDA): -248.7M vs. SNDX (-282.58M). SNDX has more cash in the bank: 454M vs. NRIX (429M). SNDX has less debt than NRIX: SNDX (1.52M) vs NRIX (56.5M). SNDX has higher revenues than NRIX: SNDX (111M) vs NRIX (83.7M).
NRIXSNDXNRIX / SNDX
Capitalization1.64B1.75B94%
EBITDA-248.7M-282.58M88%
Gain YTD-12.757-2.761462%
P/E RatioN/AN/A-
Revenue83.7M111M75%
Total Cash429M454M94%
Total Debt56.5M1.52M3,715%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXSNDX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 15 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
SNDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IASAX10.510.19
+1.84%
VY® American Century Sm-Mid Cp Val A
GLDCX47.830.30
+0.63%
Gabelli Gold C
PQDMX17.750.02
+0.11%
PGIM Quant Solutions Intl Dev Mkts IdxR6
OEICX101.83-0.52
-0.51%
JPMorgan Equity Index C
NGDCX28.50-0.33
-1.14%
Neuberger Large Cap Growth C

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-1.43%
KYMR - NRIX
72%
Closely correlated
+0.62%
SYRE - NRIX
70%
Closely correlated
-3.66%
TRDA - NRIX
70%
Closely correlated
-8.23%
IMNM - NRIX
70%
Closely correlated
-2.08%
ERAS - NRIX
69%
Closely correlated
+6.19%
More